SOURCE: Targeted Genetics

October 04, 2007 16:06 ET

Targeted Genetics to Present at Bio Investor Forum

SEATTLE, WA--(Marketwire - October 4, 2007) - Targeted Genetics Corporation (NASDAQ: TGEN) today announced that H. Stewart Parker, president and chief executive officer of Targeted Genetics, will present at the Biotechnology Industry Organization (BIO) Investor Forum on Wednesday, October 10, 2007 at 10:15 a.m. Pacific Time at The Palace Hotel in San Francisco, California. Ms. Parker will provide a corporate overview and discuss the Company's product development program for inflammatory arthritis.

The presentation will be webcast and can be accessed by visiting the "Events" section found on the Homepage of the Company's website at Additional information regarding the BIO Investor Forum can be accessed at

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at

Contact Information

  • Investor and Media Contacts:
    Stacie D. Byars
    Director, Communications
    Targeted Genetics Corporation
    (206) 521-7392 (office)